Skip to main content

Global Mannequin-Based Simulation: Market Growth, Future Prospects and Competitive Analysis, 2016-2022: Credence Research

According to the latest report published by Credence Research, Inc. “Mannequin-Based Simulation Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the mannequin-based simulation market was valued at USD 521.6 Mn in 2015, and is expected to reach USD 1,791.4 Mn by 2022, expanding at a CAGR of 25.1% from 2016 to 2022.
Market Insights                                                  
Mannequin-based simulators have become a common article in several fields such as ICUs, operating room, delivery rooms, emergency department, research and academics, military training and others. These simulators can be used across all levels of learning and experienced personnel from multidisciplinary areas. Simulated training provides healthcare and medical professionals with extensive practice opportunity in interactive settings without risking patient’s life.
Growing population of simulation-based training modules across all verticals is the major driver of this market. On the other hand, paucity of required funds may hold the growth of this market, particularly in the less developed regions. Among the various simulation types available, the patient simulators segment currently is the market leader in terms of market revenue. It will also exhibit a moderate growth rate corresponding to that of the overall mannequin-based simulation market. Ethical sensitivity about patients being made subjects and related patient safety risks, shifts taking place in medical training and treatment development are among the most significant drivers of this market.
North America and Europe are the largest regional markets for mannequin-based simulation solutions. Asia-Pacific is observed to be the fastest growing region during the forecast period. The growth of this region is attributed to the development of healthcare infrastructure, evolution of regulation bodies, rising preference for minimally invasive treatment procedures and growing demand for high quality healthcare that demands advanced training to healthcare staff and personnel.
Table of Content
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
Chapter 2 Executive Summary
2.1 Mannequin-Based Simulation Market, by Simulation Type, 2015 (USD Mn)
2.2 Mannequin-Based Simulation Market Share, by End-Users, 2015 (Value %)
2.3 Mannequin-Based Simulation Market Share, by Geography, 2015 (Value %)
Chapter 3 Mannequin-Based Simulation Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.2 Drivers
3.3 Challenges
3.4 Future Prospects
3.5 Major Commercial and Research Events
3.6 Attractive Investment Proposition
3.1 Competitive Analysis: Fractal Map Investigation, by Key Market Players
Company Profiles
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
Ph: 1-800-361-8290

Comments

Popular posts from this blog

Home Healthcare Market has Positive Long-Term Growth Outlook 2017-2023: Credence Research

Credence Research has recently issued a new market assessment report titled “Home Healthcare – Growth, Future Prospects and Competitive Analysis, 2016 – 2023”. The global Home Healthcare Market study provides a comprehensive view of the ongoing and future phases of the Home Healthcare industry based on parameters such as major commercial events, research initiatives, government guidelines, market drivers, restraints and opportunities and detailed industry segmentation and regional distribution. Browse the report at  http://www.credenceresearch.com/report/home-healthcare-market Based on geographic/regional distribution the global Home Healthcare Market is studied for key regional markets focusing on the respective geographic trends and statistics, and thereby delivering market size and forecast values. The Home Healthcare Market based on geographic classification is studied for North America, Europe, Asia-Pacific, Latin America, and...

Rheumatoid Arthritis Therapeutics Market Assessment Report Now Available at Credence Research

Credence Research has recently issued a new market assessment report titled “ Rheumatoid Arthritis Therapeutics  – Growth, Future Prospects and Competitive Analysis, 2016 – 2024”. The global Rheumatoid Arthritis Therapeutics Market study provides a comprehensive view of the ongoing and future phases of the Rheumatoid Arthritis Therapeutics industry based on parameters such as major commercial events, research initiatives, government guidelines, market drivers, restraints and opportunities and detailed industry segmentation and regional distribution. Browse the report at  http://www.credenceresearch.com/report/rheumatoid-arthritis-therapeutics-market Based on geographic/regional distribution the global Rheumatoid Arthritis Therapeutics Market is studied for key regional markets focusing on the respective geographic trends and statistics, and thereby delivering market size and forecast values. The Rheumatoid Arthritis Therapeutics Market based on geogra...

Global Liquid Biopsy Market Dynamics, Forecast, Analysis and Supply Demand 2022: Credence Research

According to the latest report published by Credence Research, Inc. “ Liquid Biopsy Market   Growth, Future Prospects and Competitive Analysis, 2016-2022,” the liquid biopsy market was valued at USD 1,881.9 Mn in 2015, and is expected to reach USD 10,850.3 Mn by 2022, expanding at a CAGR of 24.7% from 2016 to 2022. Browse the full report Liquid Biopsy: Market Growth, Future Prospects and Competitive Analysis, 2016-2022 at  http://www.credenceresearch.com/report/liquid-biopsy-market Market Insights In the past, tissue samples extracted through biopsy were evaluated to detected malignancy. However, some micrographs delivered inconsistent and ambiguous results, thus demanding repeated procedure. The advent of molecular diagnostics and next generation sequencing offered pathologists with a powerful tool for efficient diagnosis. Even with such advances, cancer diagnosis still remained subject to the limitation of availability of biopsied tissue, which fu...